Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver and kidney diseases.

Florence Wong1

  • 1Department of Medicine, Division of Gastroenterology, Toronto General Hospital, University of Toronto, 200 Elizabeth Street, Room 220, 9th Floor, Eaton Wing, M5G 2C4, ON, Canada. florence.wong@utoronto.ca

Clinics in Liver Disease
|January 9, 2003
PubMed
Summary

Renal complications in liver disease patients are increasing and impact treatment decisions, including liver transplantation and post-transplant care. Early recognition is vital for managing these complex cases and improving patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic kidney disease in cirrhosis: a study of inpatients from a global perspective.

Gut·2026
Same author

Lack of Association Between Rifaximin and Drug-resistant Infections: A global multicenter inpatient cirrhosis cohort.

Clinical and molecular hepatology·2026
Same author

Frailty Increases Hospitalization Rates in an Ambulatory Cohort of Patients With Cirrhosis: The North American Consortium for the Study of End-Stage Liver Disease 3 Prospective Cohort.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Machine Learning Models Using Hospital Admission Characteristics Do Not Optimally Predict Nosocomial Infection Development in a Global Cirrhosis Cohort.

The American journal of gastroenterology·2026
Same author

OCE-205, a selective V1a receptor mixed agonist-antagonist, for the treatment of hepatorenal syndrome-acute kidney injury: A phase 2 randomized trial.

Hepatology (Baltimore, Md.)·2026
Same author

The management of hepatorenal syndrome-acute kidney injury (HRS-AKI): A national survey of hepatology provider practices.

Hepatology communications·2026

Area of Science:

  • Nephrology
  • Hepatology
  • Transplantation Medicine

Background:

  • The spectrum of kidney diseases associated with liver conditions is broadening.
  • Recognizing renal complications is crucial for managing patients with liver disease.
  • Systemic conditions frequently involve both liver and kidney, increasing patient morbidity and mortality.

Purpose of the Study:

  • To highlight the importance of identifying renal complications in liver disease patients.
  • To discuss the impact of renal complications on liver transplantation decisions and outcomes.
  • To emphasize the role of renal function in post-transplant immunosuppressive therapy.

Main Methods:

  • Review of current literature on hepatorenal syndromes and renal manifestations of liver disease.

Related Experiment Videos

  • Analysis of clinical implications for liver transplant candidates and recipients.
  • Discussion of diagnostic and management strategies for renal dysfunction in liver disease.

    • Main Results:

    • Renal complications significantly affect the management and prognosis of liver disease patients.
    • The presence of kidney disease influences eligibility and outcomes of liver transplantation.
    • Post-transplant immunosuppression requires careful consideration of renal function.

    Conclusions:

    • Integrated management of liver and kidney diseases is essential.
    • Proactive renal assessment improves outcomes for liver disease patients undergoing transplantation.
    • Understanding the interplay between liver and kidney function is critical for patient care.